Health Care & Life Sciences » Biotechnology | Endonovo Therapeutics Inc.

Endonovo Therapeutics Inc.

Endonovo Therapeutics Inc.
Stock Exchange Other OTC
EPS
$0.02
Market Cap
$9.77 M
Shares Outstanding
558.16 M
Public Float
385.89 M

Profile

Address
6320 Canoga Avenue
Woodland Hills California 91367
United States
Employees -
Website http://www.endonovo.com
Updated 07/08/2019
Endonovo Therapeutics, Inc. is a biotechnology company, which engages in developing off bioelectronic approach to regenerative medicine. It operates through the Intellectual Property Management and Commercialization segment. The company was founded on May 26, 2011 and is headquartered in Woodland Hills, CA.

Financials

View All
Created with Highcharts 5.0.14Endonovo Therapeutics Inc.Net Income. Fiscal year is January-December. All values USD Thousands.2 8922 8929599596 7656 7655 3155 31510 81010 8106 4356 43520132014201520162017201802.5k5k7.5k10k12.5k
Created with Highcharts 5.0.14Endonovo Therapeutics Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.222224244400008383201320142015201620172018020406080100

Alan Brian Collier
Chairman, CEO, CFO & Secretary
Alan Brian Collier
Chairman, CEO, CFO & Secretary